Fundz

ScopeBio raises €6 million in seed funding for smart DNA CRISPR tests, backed by SHIFT Invest and Oost NL.

PRIVATEJun 16, 2025

Amount Raised

€6 Million

Round Type

Seed

WageningenBiotechnology

Investors

Oost NLShift Invest

Description

Scope Biosciences, a spin-off from Wageningen University & Research, has secured an investment from SHIFT Invest and Oost NL. This funding marks a significant step for the company following its first commercial traction. The funds will help advance their CRISPR-based diagnostic platform, scopeDx®. It aims to improve diagnostics in agriculture and healthcare.

Quick answer

Scope Biosciences raised €6 Million in a Seed round, dated June 16, 2025. Investors: Oost NL and Shift Invest. Scope Biosciences is based in Wageningen, Gelderland, Netherlands.

How much did Scope Biosciences raise?
Scope Biosciences raised €6 Million in a Seed round on June 16, 2025.
Who invested in Scope Biosciences?
Oost NL and Shift Invest are named as investors in this round.
What does Scope Biosciences do?
Scope Biosciences is a spin-off from Wageningen University & Research focused on developing the scopeDx® CRISPR-based diagnostic platform.
Where is Scope Biosciences based and how big is it?
Scope Biosciences is based in Wageningen, Gelderland, Netherlands.
Who are the decision-makers at Scope Biosciences?
Fundz holds 1 contact at Scope Biosciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Scope Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • IM Cannabis Corp raised $4.1M (Post-IPO Equity) on July 31, 2025.
  • Genvira Biosciences raised $1.6M (Seed) on July 31, 2025.
  • Cotton Mouton Diagnostics raised $668K on July 31, 2025.
  • FibroBiologics raised $5M (Funding Round) on July 31, 2025.
  • Ultromics raised $55M (Series C) on July 31, 2025.
  • Conformal Medical raised $32M on July 31, 2025.

Who to call at Scope Biosciences, and when

A new round usually means Scope Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Scope Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Scope Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Scope Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Scope Biosciences

Location

Wageningen, Gelderland, Netherlands

About

Scope Biosciences is a spin-off from Wageningen University & Research focused on developing the scopeDx® CRISPR-based diagnostic platform. This technology allows for ultra-precise DNA detection without the need for special equipment or labs, enabling diagnostics closer to the source in agriculture and healthcare. It aims to improve crop disease detection and provide reliable testing in areas lacking centralized laboratories.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Scope Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Scope Biosciences's next move

See what Strategic adds

Scope Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.